Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27 - 30 October 2025

View source ↗

Summary

The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) agreed to issue a safety communication to healthcare professionals about injectable tranexamic acid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Hemorrhage
• Postpartum Hemorrhage
• Surgical Bleeding

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

PRAC agrees on a communication to healthcare professionals on injectable tranexamic acid medicines